Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H B Koon

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Current Opinion in Oncology|November 21, 2000
Anti-CD30 antibody-based therapyH B Koon, R P Junghans
Leukemia Research|September 17, 2005
Antileukemic effect of daclizumab in CD25 high-expressing leukemias and impact of tumor burden on antibody dosingH B Koon, P Severy, D S Hagg, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Current Opinion in Oncology|November 21, 2000
Anti-CD30 antibody-based therapyH B Koon, R P Junghans
Leukemia Research|September 17, 2005
Antileukemic effect of daclizumab in CD25 high-expressing leukemias and impact of tumor burden on antibody dosingH B Koon, P Severy, D S Hagg, et al.
Pageof 1